Molecular
imaging along with combinations of imaging modalities
can provide a thorough understanding of disease, in particular, tumors.
Magnetic resonance imaging (MRI) offers exceptional tissue contrast
and resolution; whereas optical imaging provides high sensitivity.
Hence a norbornene based copolymer (<b>Nor-Cob-Py-Fol</b>) is
reported in this paper as a dual-imaging agent. <b>Nor-Cob-Py-Fol</b> having Co<sup>2+</sup> complex, pyrene and poly(ethylene glycol)
derived folate, have been synthesized using ring-opening metathesis
polymerization (<b>ROMP</b>). All the monomers and polymers
are characterized by <sup>1</sup>H NMR, IR, GPC, and TGA techniques.
The morphology of the copolymer nanoaggregates has been evaluated
with DLS, TEM, and SEM techniques. The functionalization of Co<sup>2+</sup> to the polymer is monitored by FTIR, <sup>1</sup>H NMR,
and <sup>13</sup>C NMR spectroscopy. Furthermore, the presence of
Co<sup>2+</sup> in the nanoaggregates is confirmed by the EDX (SEM)
technique. To prove the MRI capabilities nature of copolymer nanoaggregates,
NMR experiment is performed at room temperature. Cell viability studies
suggest the biocompatibility nature of the copolymer. Flow cytometry
as well as epifluoroscence microscope experiments clearly demonstrate
the dual-imaging ability of the newly designed copolymer. The much
higher relaxivity ratio (<i>r</i><sub>2</sub>/<i>r</i><sub>1</sub>) of the present method clearly establishes the superiority
of our system as one of the best contrast agents known to the practitioners
of magnetic resonance imaging